EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity

Stephen T Hammond iD, Lukas Brandt iD, Amanda L Kong iD, Sarah B White, David Lewandowski, Andreas M Beyer iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-06 · 46 (6)

DOI: 10.1161/atvbaha.125.319865 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-06. Verfasst von Stephen T Hammond und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee. Hauptthemen laut MEDLINE: Anthracyclines, Nanoparticles, Neoplasms, Antibiotics, Antineoplastic. Die Arbeit nennt 224 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer survivors are at an increased risk for major adverse cardiovascular events and cardiovascular disease mortality compared with the general population. In fact, emerging evidence suggests that cardiovascular disease is the leading cause of mortality 10 years into survivorship for some cancer populations. While this heightened cardiovascular risk undoubtedly involves a variety of factors, antineoplastic therapies, such as anthracyclines, are known to contribute significantly to this pathology. As such, modalities that improve the localization of treatments to the tumor while simultaneously minimizing off-target effects on noncancerous cells are greatly needed. Approaches in which anthracyclines are injected directly into tumor-feeding arterioles (locoregional/intra-arterial administration) or are encapsulated in tumor-directed nanoparticles have gained prominence in certain cancers. Such therapies should direct cardiotoxic chemotherapy away from sites of potential toxicity while leaving the tumor exposed. However, current clinical findings on the efficacy and cardiovascular safety of these treatments remain inconclusive, and their use for many cancers is limited. This narrative review aims to highlight current clinical findings that have evaluated the safety and efficacy of locoregional and nanoparticle-mediated anthracycline administration as they compare with systemic delivery and identify avenues to be explored by future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesNanoparticlesNeoplasmsAntibiotics, AntineoplasticHeart DiseasesHumansCardiotoxicityAnimalsTreatment OutcomeRisk AssessmentRisk Factors

Stichwörter der Autor:innen

antineoplastic agentscardio-oncologydoxorubicinnanomedicineneoplasms

Substanzen

AnthracyclinesAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Medicine (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee.
  • Cardiovascular Research Center (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee.
  • Division of Surgical Oncology, Department of Surgery (A.L.K.), Medical College of Wisconsin, Milwaukee.
  • Division of Vascular and Interventional Radiology, Department of Radiology (S.B.W.), Medical College of Wisconsin, Milwaukee.
  • Department of Physiology (A.M.B.), Medical College of Wisconsin, Milwaukee.
  • Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio (A.M.B.).

ORCID-Profile: Stephen T Hammond, Lukas Brandt, Amanda L Kong, Andreas M Beyer

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Hammond, S. T., Brandt, L., Kong, A. L., White, S. B., Lewandowski, D., & Beyer, A. M. (2026). Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(6). https://doi.org/10.1161/atvbaha.125.319865

Vancouver

Hammond ST, Brandt L, Kong AL, White SB, Lewandowski D, Beyer AM. Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(6). doi:10.1161/atvbaha.125.319865

BibTeX
@article{Hammond2026,
  author = {Hammond, Stephen T and Brandt, Lukas and Kong, Amanda L and White, Sarah B and Lewandowski, David and Beyer, Andreas M},
  title = {Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  volume = {46},
  number = {6},
  doi = {10.1161/atvbaha.125.319865}
}
Kostenlos starten →